What the FDA labels say about taking them together
Cortisone and tesamorelin
Tesamorelin's FDA label of July 29, 2026 names cortisone in its drug interactions section; the cortisone label PlainMeds reads does not name tesamorelin.
Check it at the source: the cortisone FDA label on DailyMed (effective June 6, 2025, Chartwell RX, LLC); the tesamorelin FDA label on DailyMed (effective July 29, 2026, Theratechnologies Inc.).
What does the cortisone label say about tesamorelin?
Cortisone's label (effective June 6, 2025) does not name tesamorelin in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Cortisone Acetate), Chartwell RX, LLC, effective June 6, 2025 (SPL set cc158d11-f356-4696-8b73-5d2681dcbcf2), via openFDA; the full label on DailyMed
What does the tesamorelin label say about cortisone?
Tesamorelin label, drug interactionsGlucocorticoids GH inhibits 11β-hydroxysteroid dehydrogenase type 1 (11βHSD-1), a microsomal enzyme required for conversion of cortisone to its active metabolite, cortisol, in hepatic and adipose tissue.
Source: FDA drug label (EGRIFTA SV), Theratechnologies Inc., effective July 29, 2026 (SPL set 3d783378-b02d-4f19-99dd-0fc91a042224), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Cortisone | Tesamorelin | |
|---|---|---|
| Labeled for | Osteoarthritis, Asthma, Allergies, Herpes and shingles, Leukemia, lymphoma and myeloma, Crohn's disease and ulcerative colitis | n/a |
| Boxed warning | No | No |
| Pharmacy cost (NADAC) | n/a | n/a |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once